Download PDF
1 / Pages

Other users also viewed these articles

Serum determination of MMP-2 and MMP-9 in chronic liver disease according to alcohol consumption, non-alcoholic fatty liver disease and hepatitis C M Lemus-Peña; D Montes de Oca-Ángeles; M Hernandez-Santillan; A Hernandez-Barragan; D Santana-Vargas; M Martinez-Castillo; Z Medina-Avila; A Torre-Delgadillo; JL Pérez-Hernández; F Higuera-De la Tijera; P Cordero-Pérez; L Muñoz-Espinosa; D Kershenobich; G Gutiérrez-Reyes;
Ann Hepatol. 2022;27 Supl 3:
Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption M Hernandez-Santillan; M Martínez-Castillo; Z Medina-Ávila; M Lemus-Peña; D Montes de Oca-Ángeles; A Hernández-Barragan; JL Pérez-Hernández; F Higuera-De la Tijera; D Santana-Vargas; P Cordero-Pérez; L Muñoz-Espinoza; J Córdova-Gallardo; D Kershenobich; G Gutiérrez-Reyes;
Ann Hepatol. 2022;27 Supl 3:
MMP-7 is a non-invasive biomarker of chronic liver diseases D Montes de Oca-Angeles; M Lemus-Peña; A Hernandez-Barragan; M Hernández-Santillán; M Martinez-Castillo; D Santana-Vargas; Z Medina-Avila; A Torre-Delgadillo; JL Pérez-Hernández; F Higuera-De la Tijera; P Cordero-Pérez; L Muñoz-Espinosa; D Kershenobich; G Gutiérrez-Reyes;
Ann Hepatol. 2022;27 Supl 3: